Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2476
SEACOR Marine Holdings
SMHI
$236M
| $1.08M | ﹤0.01% |
212,400
+42,100
| +25% | +$213K |
2020 Q4
18 quarters
|
|
2477
Metalla Royalty & Streaming
MTA
$799M
| $1.08M | ﹤0.01% |
281,800
+76,300
| +37% | +$243K |
2024 Q2
4 quarters
|
|
2478
iShares International Treasury Bond ETF
IGOV
$1.31B
| $1.08M | ﹤0.01% |
+25,100
| New | +$1.04M |
2025 Q2
0 quarters
|
|
2479
Hesai Group
HSAI
$2.38B
| $1.08M | ﹤0.01% |
49,200
-202,500
| -80% | -$3.56M |
2024 Q4
2 quarters
|
|
2480
Cerus
CERS
$455M
| $1.08M | ﹤0.01% |
765,500
-603,900
| -44% | -$805K |
2020 Q4
18 quarters
|
|
2481
DoubleVerify
DV
$2.11B
| $1.08M | ﹤0.01% |
+72,100
| New | +$988K |
2025 Q2
0 quarters
|
|
2482
Bilibili
BILI
$6.26B
| $1.08M | ﹤0.01% |
+50,200
| New | +$924K |
2025 Q2
0 quarters
|
|
2483
1stdibs.com
DIBS
$123M
| $1.07M | ﹤0.01% |
390,130
+127,730
| +49% | +$331K |
2022 Q1
13 quarters
|
|
2484
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14.3B
| $1.07M | ﹤0.01% |
14,300
+6,700
| +88% | +$465K |
2023 Q2
8 quarters
|
|
2485
First Bank
FRBA
$437M
| $1.07M | ﹤0.01% |
68,856
+4,200
| +6% | +$60.8K |
2016 Q4
34 quarters
|
|
2486
Digimarc Corp
DMRC
$144M
| $1.06M | ﹤0.01% |
80,600
+68,800
| +583% | +$883K |
2023 Q1
9 quarters
|
|
2487
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.9B
| $1.06M | ﹤0.01% |
7,800
-5,500
| -41% | -$693K |
2023 Q2
8 quarters
|
|
2488
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.8B
| $1.06M | ﹤0.01% |
8,100
-14,700
| -64% | -$1.84M |
2022 Q4
10 quarters
|
|
2489
Sanara MedTech
SMTI
$323M
| $1.06M | ﹤0.01% |
37,400
+3,100
| +9% | +$93K |
2023 Q3
7 quarters
|
|
2490
Corbus Pharmaceuticals
CRBP
$102M
| $1.06M | ﹤0.01% |
153,539
-191,661
| -56% | -$1.39M |
2024 Q3
3 quarters
|
|
2491
Cactus
WHD
$4.39B
| $1.05M | ﹤0.01% |
24,100
-104,800
| -81% | -$4.37M |
2023 Q4
6 quarters
|
|
2492
Neumora Therapeutics
NMRA
$82.2M
| $1.05M | ﹤0.01% |
1,434,527
+174,997
| +14% | +$133K |
2025 Q1
1 quarter
|
|
2493
Skillsoft
SKIL
$57M
| $1.05M | ﹤0.01% |
65,780
+1,916
| +3% | +$36.2K |
2022 Q3
11 quarters
|
|
2494
OptimizeRx
OPRX
$155M
| $1.05M | ﹤0.01% |
+77,707
| New | +$850K |
2025 Q2
0 quarters
|
|
2495
Transact Technologies
TACT
$45.1M
| $1.05M | ﹤0.01% |
285,737
| – | – |
2013 Q2
48 quarters
|
|
2496
Vanguard Financials ETF
VFH
$13.1B
| $1.04M | ﹤0.01% |
+8,200
| New | +$978K |
2025 Q2
0 quarters
|
|
2497
RGC Resources
RGCO
$236M
| $1.04M | ﹤0.01% |
46,633
+900
| +2% | +$19.1K |
2018 Q3
27 quarters
|
|
2498
Schwab 5-10 Year Corporate Bond ETF
SCHI
$10.8B
| $1.04M | ﹤0.01% |
+45,800
| New | +$1.02M |
2025 Q2
0 quarters
|
|
2499
Playboy Inc
PLBY
$119M
| $1.04M | ﹤0.01% |
643,127
+142,360
| +28% | +$183K |
2024 Q3
3 quarters
|
|
2500
Hurco Companies Inc
HURC
$138M
| $1.04M | ﹤0.01% |
55,100
+1,600
| +3% | +$24.1K |
2014 Q4
42 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.